Abstract
Alzheimer’s disease (AD) is a neurodegenerative disorder clinically manifested by a gradual cognitive decline. Intracerebroventricular injection (ICV) of streptozotocin (STZ), a model of sporadic AD (sAD), shows many aspects of sAD abnormalities (i.e., neuroinflammation, oxidative stress, protein aggregation), resulting in memory impairment. Andrographolide (ANDRO), a natural diterpene lactone, has numerous bioactivities including anti-inflammatory and antioxidant properties. Studies in rodents revealed that ANDRO has neuroprotective properties and restores cognitive impairment. In the present study, we investigated the effects of ANDRO in the ICV-STZ model relative to short-term spatial memory (object location test (OLT) and Y maze test), short-term recognition memory (object recognition test (ORT)), locomotor activity (open field test (OFT)), expression of amyloid precursor protein (APP), and activation of astrocytes (glial fibrillary acidic protein (GFAP) expression) and microglia (ionized calcium-binding adapter molecule-1 (Iba-1) immunohistochemistry) in the prefrontal cortex (PFC) and hippocampus (HIP). Wistar rats were injected ICV with STZ (3 mg/kg) or vehicle and treated with ANDRO (2 mg/kg, i.p.; three times per week). After four weeks, ANDRO attenuated the impairments of the Y maze and ORT performances, and the increase of astrocyte activation in the PFC induced by the ICV-STZ model. In addition, ANDRO decreased the number of activated microglia cells in the HIP of STZ-injected rats. The APP expression was not altered, neither by the STZ nor ANDRO. ANDRO showed a beneficial effect on memory impairment and neuroinflammation in the STZ model of AD.
Similar content being viewed by others
References
Anand R, Gill KD, Mahdi AA (2014) Therapeutics of Alzheimer’s disease: Past, present and future. Neuropharmacology 76(PART A):27–50. https://doi.org/10.1016/j.neuropharm.2013.07.004
Arredondo SB, Reyes DT, Herrera-Soto A, Mardones MD, Inestrosa NC, Varela-Nallar L (2021) Andrographolide promotes hippocampal neurogenesis and spatial memory in the APPswe/PS1ΔE9 mouse model of Alzheimer’s disease. Sci Rep 11(1):22904. https://doi.org/10.1038/s41598-021-01977-x
Bassani TB, Bonato JM, Machado MMF, Cóppola-Segovia V, Moura ELR, Zanata SM, Oliveira RMMW, Vital MABF (2017a) Decrease in adult neurogenesis and neuroinflammation are involved in spatial memory impairment in the streptozotocin-induced model of sporadic Alzheimer’s disease in rats. Mol Neurobiol. https://doi.org/10.1007/s12035-017-0645-9
Bassani TB, Turnes JM, Moura ELR, Bonato JM, Cóppola-Segovia V, Zanata SM, Oliveira RMMW, Vital MABF (2017b) Effects of curcumin on short-term spatial and recognition memory, adult neurogenesis and neuroinflammation in a streptozotocin-induced rat model of dementia of Alzheimer’s type. Behav Brain Res 335(July):41–54. https://doi.org/10.1016/j.bbr.2017.08.014
Blennow K, de Leon MJ, Zetterberg H (2006) Alzheimer’s disease. Lancet 368(9533):387–403. https://doi.org/10.1016/S0140-6736(06)69113-7
Chan SJ, Wong WSF, Wong PTH, Bian JS (2010) Neuroprotective effects of andrographolide in a rat model of permanent cerebral ischaemia. Br J Pharmacol 161(3):668–679. https://doi.org/10.1111/j.1476-5381.2010.00906.x
Chen Y, Guo Z, Mao Y-F, Zheng T, Zhang B (2018) Intranasal insulin ameliorates cerebral hypometabolism, neuronal loss, and astrogliosis in streptozotocin-induced Alzheimer’s rat model. Neurotox Res 33(4):716–724. https://doi.org/10.1007/s12640-017-9809-7
Choleris E (2001) A detailed ethological analysis of the mouse open field test: effects of diazepam, chlordiazepoxide and an extremely low frequency pulsed magnetic field. Neurosci Biobehav Rev 25(3):235–260. https://doi.org/10.1016/S0149-7634(01)00011-2
Cisternas P, Oliva CA, Torres VI, Barrera DP, Inestrosa NC (2019a) Presymptomatic treatment with andrographolide improves brain metabolic markers and cognitive behavior in a model of early-onset Alzheimer’s disease. Front Cell Neurosci 13(July):1–18. https://doi.org/10.3389/fncel.2019.00295
Cisternas P, Zolezzi JM, Martinez M, Torres VI, Wong GW, Inestrosa NC (2019b) Wnt-induced activation of glucose metabolism mediates the in vivo neuroprotective roles of Wnt signaling in Alzheimer disease. J Neurochem 149(1):54–72. https://doi.org/10.1111/jnc.14608
Correia SC, Santos RX, Perry G, Zhu X, Moreira PI, Smith MA (2011) Insulin-resistant brain state: The culprit in sporadic Alzheimer’s disease? Ageing Res Rev 10(2):264–273. https://doi.org/10.1016/j.arr.2011.01.001
Cummings JL (2004) Alzheimer’s disease. N Engl J Med 351(1):56–67. https://doi.org/10.1056/NEJMra040223
de Bruin NMWJ, Prickaerts J, van Loevezijn A, Venhorst J, de Groote L, Houba P, Reneerkens O, Akkerman S, Kruse CG (2011) Two novel 5-HT6 receptor antagonists ameliorate scopolamine-induced memory deficits in the object recognition and object location tasks in Wistar rats. Neurobiol Learn Mem 96(2):392–402. https://doi.org/10.1016/j.nlm.2011.06.015
Dellu F, Fauchey V, Moal ML, Simon H (1997) Extension of a new two-trial memory task in the rat: influence of environmental context on recognition processes. Neurobiol Learn Mem 67(2):112–120. https://doi.org/10.1006/nlme.1997.3746
Dhami M, Raj K, Singh S (2021) Neuroprotective effect of fucoxanthin against intracerebroventricular streptozotocin (ICV-STZ) induced cognitive impairment in experimental rats. Curr Alzheimer Res 18(8):623–637. https://doi.org/10.2174/1567205018666211118144602
Diz-Chaves Y, Pernía O, Carrero P, Garcia-Segura LM (2012) Prenatal stress causes alterations in the morphology of microglia and the inflammatory response of the hippocampus of adult female mice. J Neuroinflammation 9(1):580. https://doi.org/10.1186/1742-2094-9-71
Eichenbaum H (2017) On the integration of space, time, and memory. Neuron 95(5):1007–1018. https://doi.org/10.1016/j.neuron.2017.06.036
el Sayed NS, Ghoneum MH (2020) Antia, a natural antioxidant product, attenuates cognitive dysfunction in streptozotocin-induced mouse model of sporadic Alzheimer’s disease by targeting the amyloidogenic, inflammatory, autophagy, and oxidative stress pathways. Oxid Med Cell Longev. https://doi.org/10.1155/2020/4386562
Geng J, Liu W, Gao J, Jiang C, Fan T, Sun Y, Qin Z, Xu Q, Guo W, Gao J (2019) Andrographolide alleviates Parkinsonism in MPTP-PD mice via targeting mitochondrial fission mediated by dynamin-related protein 1. Br J Pharmacol 176(23):4574–4591. https://doi.org/10.1111/bph.14823
Gerzson MFB, Bona NP, Soares MSP, Teixeira FC, Rahmeier FL, Carvalho FB, da Cruz Fernandes M, Onzi G, Lenz G, Gonçales RA, Spanevello RM, Stefanello FM (2020) Tannic acid ameliorates STZ-induced Alzheimer’s disease-like impairment of memory, neuroinflammation, neuronal death and modulates Akt expression. Neurotox Res 37(4):1009–1017. https://doi.org/10.1007/s12640-020-00167-3
Grieb P (2016) Intracerebroventricular streptozotocin injections as a model of Alzheimer’s disease: in search of a relevant mechanism. Mol Neurobiol 53(3):1741–1752. https://doi.org/10.1007/s12035-015-9132-3
Guan S, Tee W, Ng D, Chan T, Peh H, Ho W, Cheng C, Mak J, Wong W (2013) Andrographolide protects against cigarette smoke-induced oxidative lung injury via augmentation of Nrf2 activity. Br J Pharmacol 168(7):1707–1718. https://doi.org/10.1111/bph.12054
Guo Z, Chen Y, Mao Y-F, Zheng T, Jiang Y, Yan Y, Yin X, Zhang B (2017) Long-term treatment with intranasal insulin ameliorates cognitive impairment, tau hyperphosphorylation, and microglial activation in a streptozotocin-induced Alzheimer’s rat model. Sci Rep 7(1):45971. https://doi.org/10.1038/srep45971
Gupta S, Yadav K, Mantri SS, Singhal NK, Ganesh S, Sandhir R (2018) Evidence for compromised insulin signaling and neuronal vulnerability in experimental model of sporadic Alzheimer’s disease. Mol Neurobiol 55(12):8916–8935. https://doi.org/10.1007/s12035-018-0985-0
Heneka MT, Carson MJ, el Khoury J, Landreth GE, Brosseron F, Feinstein DL, Jacobs AH, Wyss-Coray T, Vitorica J, Ransohoff RM, Herrup K, Frautschy SA, Finsen B, Brown GC, Verkhratsky A, Yamanaka K, Koistinaho J, Latz E, Halle A, Kummer MP (2015) Neuroinflammation in Alzheimer’s disease. Lancet Neurol 14(4):388–405. https://doi.org/10.1016/S1474-4422(15)70016-5
Hindam MO, Sayed RH, Skalicka-Woźniak K, Budzyńska B, el Sayed NS (2020) Xanthotoxin and umbelliferone attenuate cognitive dysfunction in a streptozotocin-induced rat model of sporadic Alzheimer’s disease: The role of JAK2/STAT3 and Nrf2/HO-1 signalling pathway modulation. Phytother Res. https://doi.org/10.1002/ptr.6686
Hossain R, Quispe C, Herrera-Bravo J, Beltrán JF, Islam MT, Shaheen S, Cruz-Martins N, Martorell M, Kumar M, Sharifi-Rad J, Ozdemir FA, Setzer WN, Alshehri MM, Calina D, Cho WC (2022) Neurobiological promises of the bitter diterpene lactone andrographolide. Oxid Med Cell Longev. https://doi.org/10.1155/2022/3079577
Kanazawa LKS, Radulski DR, Pereira GS, Prickaerts J, Schwarting RKW, Acco A, Andreatini R (2021) Andrographolide blocks 50-kHz ultrasonic vocalizations, hyperlocomotion and oxidative stress in an animal model of mania. J Psychiatr Res 139(March):91–98. https://doi.org/10.1016/j.jpsychires.2021.05.042
Kaur D, Sharma V, Deshmukh R (2019) Activation of microglia and astrocytes: a roadway to neuroinflammation and Alzheimer’s disease. Inflammopharmacology 27(4):663–677. https://doi.org/10.1007/s10787-019-00580-x
Kraeuter A, Guest PC, Sarnyai Z (2019) The Y-maze for assessment of spatial working and reference memory in mice (Vol 1916, pp 105–111). https://doi.org/10.1007/978-1-4939-8994-2_10
Kraska A, Santin MD, Dorieux O, Joseph-Mathurin N, Bourrin E, Petit F, Jan C, Chaigneau M, Hantraye P, Lestage P, Dhenain M (2012) In vivo cross-sectional characterization of cerebral alterations induced by intracerebroventricular administration of streptozotocin. PLoS ONE 7(9):e46196. https://doi.org/10.1371/journal.pone.0046196
Kumar A, Singh A, Ekavali (2015) A review on Alzheimer’s disease pathophysiology and its management: an update. Pharmacol Rep 67(2):195–203. https://doi.org/10.1016/j.pharep.2014.09.004
Lane CA, Hardy J, Schott JM (2018) Alzheimer’s disease. Eur J Neurol 25(1):59–70. https://doi.org/10.1111/ene.13439
Li C, Liu W, Li X, Zhang Z, Qi H, Liu S, Yan N, Xing Y, Hölscher C, Wang Z (2020) The novel GLP-1/GIP analogue DA5-CH reduces tau phosphorylation and normalizes theta rhythm in the icv. STZ rat model of AD. Brain Behav 10(3):1–13. https://doi.org/10.1002/brb3.1505
Li Y, Yan H, Zhang Z, Zhang G, Sun Y, Yu P, Wang Y, Xu L (2015) Andrographolide derivative AL-1 improves insulin resistance through down-regulation of NF-κB signalling pathway. Br J Pharmacol 172(12):3151–3158. https://doi.org/10.1111/bph.13118
Lu J, Ma Y, Wu J, Huang H, Wang X, Chen Z, Chen J, He H, Huang C (2019) A review for the neuroprotective effects of andrographolide in the central nervous system. Biomed Pharmacother 117:109078. https://doi.org/10.1016/j.biopha.2019.109078
Martin SJ, Clark RE (2007) The rodent hippocampus and spatial memory: from synapses to systems. Cell Mol Life Sci 64(4):401–431. https://doi.org/10.1007/s00018-007-6336-3
More SV, Kumar H, Cho DY, Yun YS, Choi DK (2016) Toxin-induced experimental models of learning and memory impairment. Int J Mol Sci. https://doi.org/10.3390/ijms17091447
Moura ELR, dos Santos H, Celes APM, Bassani TB, Souza LC, Vital MABF (2020) Effects of a nutritional formulation containing caprylic and capric acid, phosphatidylserine, and docosahexaenoic acid in Streptozotocin-lesioned rats. J Alzheimers Dis Rep 4(1):353–363. https://doi.org/10.3233/ADR-200175
Patel R, Kaur K, Singh S (2021) Protective effect of andrographolide against STZ induced Alzheimer’s disease in experimental rats: possible neuromodulation and Aβ(1–42) analysis. Inflammopharmacology 29(4):1157–1168. https://doi.org/10.1007/s10787-021-00843-6
Paxinos G, Watson CR (2007) The rat brain in stereotaxic coordinates (6th ed.). Academic Press
Pierzynowska K, Podlacha M, Gaffke L, Majkutewicz I, Mantej J, Węgrzyn A, Osiadły M, Myślińska D, Węgrzyn G (2019) Autophagy-dependent mechanism of genistein-mediated elimination of behavioral and biochemical defects in the rat model of sporadic Alzheimer’s disease. Neuropharmacology 148:332–346. https://doi.org/10.1016/j.neuropharm.2019.01.030
Pilipenko V, Narbute K, Pupure J, Langrate IK, Muceniece R, Kluša V (2020) Neuroprotective potential of antihyperglycemic drug metformin in streptozocin-induced rat model of sporadic Alzheimer’s disease. Eur J Pharmacol 881:173290. https://doi.org/10.1016/j.ejphar.2020.173290
Pilipenko V, Narbute K, Pupure J, Rumaks J, Jansone B, Klusa V (2019) Neuroprotective action of diazepam at very low and moderate doses in Alzheimer’s disease model rats. Neuropharmacology 144:319–326. https://doi.org/10.1016/j.neuropharm.2018.11.003
Prickaerts J, Fahrig T, Blokland A (1999) Cognitive performance and biochemical markers in septum, hippocampus and striatum of rats after an i.c.v. injection of streptozotocin: a correlation analysis. Behav Brain Res 102(1–2):73–88. https://doi.org/10.1016/S0166-4328(98)00158-2
Prince M, Bryce R, Albanese E, Wimo A, Ribeiro W, Ferri CP (2013) The global prevalence of dementia: A systematic review and metaanalysis. Alzheimers Dement 9(1):63. https://doi.org/10.1016/j.jalz.2012.11.007
Querfurth HW, LaFerla FM (2010) Alzheimer’s disease. N Engl J Med 362(4):329–344. https://doi.org/10.1056/NEJMra0909142
Rai S, Kamat PK, Nath C, Shukla R (2014) Glial activation and post-synaptic neurotoxicity: The key events in Streptozotocin (ICV) induced memory impairment in rats. Pharmacol Biochem Behav 117:104–117. https://doi.org/10.1016/j.pbb.2013.11.035
Rajasekar N, Nath C, Hanif K, Shukla R (2017) Intranasal insulin administration ameliorates streptozotocin (ICV)-induced insulin receptor dysfunction, neuroinflammation, amyloidogenesis, and memory impairment in rats. Mol Neurobiol 54(8):6507–6522. https://doi.org/10.1007/s12035-016-0169-8
Ravelli KG, dos Anjos Rosário B, Camarini R, Hernandes MS, Britto LR (2017) Intracerebroventricular streptozotocin as a model of Alzheimer’s disease: neurochemical and behavioral characterization in mice. Neurotox Res 31(3):327–333. https://doi.org/10.1007/s12640-016-9684-7
Retinasamy T, Shaikh MF, Kumari Y, Abidin SAZ, Othman I (2020) Orthosiphon stamineus standardized extract reverses streptozotocin-induced alzheimer’s disease-like condition in a rat model. Biomedicines 8(5):1–15. https://doi.org/10.3390/BIOMEDICINES8050104
Rivera DS, Lindsay C, Codocedo JF, Morel I, Pinto C, Cisternas P, Bozinovic F, Inestrosa NC (2016) Andrographolide recovers cognitive impairment in a natural model of Alzheimer’s disease (Octodon degus). Neurobiol Aging 46:204–220. https://doi.org/10.1016/j.neurobiolaging.2016.06.021
Rodrigues L, Dutra MF, Ilha J, Biasibetti R, Quincozes-Santos A, Leite MC, Marcuzzo S, Achaval M, Gonçalves C-A (2010) Treadmill training restores spatial cognitive deficits and neurochemical alterations in the hippocampus of rats submitted to an intracerebroventricular administration of streptozotocin. J Neural Transm 117(11):1295–1305. https://doi.org/10.1007/s00702-010-0501-9
Salardini A (2019) An overview of primary dementias as clinicopathological entities. Semin Neurol 39(02):153–166. https://doi.org/10.1055/s-0039-1683445
Salkovic-Petrisic M, Hoyer S (2007) Central insulin resistance as a trigger for sporadic Alzheimer-like pathology: an experimental approach. In Neuropsychiatric disorders An integrative approach (pp 217–233). Springer Vienna. https://doi.org/10.1007/978-3-211-73574-9_28
Salkovic-Petrisic M, Knezovic A, Hoyer S, Riederer P (2013) What have we learned from the streptozotocin-induced animal model of sporadic Alzheimer’s disease, about the therapeutic strategies in Alzheimer’s research. J Neural Transm 120(1):233–252. https://doi.org/10.1007/s00702-012-0877-9
Serrano FG, Tapia-Rojas C, Carvajal FJ, Hancke J, Cerpa W, Inestrosa NC (2014) Andrographolide reduces cognitive impairment in young and mature AβPPswe/PS-1 mice. Mol Neurodegener 9(1):61. https://doi.org/10.1186/1750-1326-9-61
Serrano-Pozo A, Frosch MP, Masliah E, Hyman BT (2011) Neuropathological alterations in Alzheimer Disease. Cold Spring Harb Perspect Med 1(1):a006189–a006189. https://doi.org/10.1101/cshperspect.a006189
Sharma Y, Garabadu D (2020) Intracerebroventricular streptozotocin administration impairs mitochondrial calcium homeostasis and bioenergetics in memory-sensitive rat brain regions. Exp Brain Res 238(10):2293–2306. https://doi.org/10.1007/s00221-020-05896-7
Sirwi A, el Sayed NS, Abdallah HM, Ibrahim SRM, Mohamed GA, El-Halawany AM, Safo MK, Abdel Rasheed NO (2021) Umuhengerin neuroprotective effects in streptozotocin-induced Alzheimer’s disease mouse model via targeting Nrf2 and NF-Kβ signaling cascades. Antioxidants 10(12):2011. https://doi.org/10.3390/antiox10122011
Stella F, Radanovic M, Canineu PR, de Paula VJR, Forlenza OV (2015) Anti-dementia medications: current prescriptions in clinical practice and new agents in progress. Ther Adv Drug Saf 6(4):151–165. https://doi.org/10.1177/2042098615592116
Tao L, Zhang L, Gao R, Jiang F, Cao J, Liu H (2018) Andrographolide alleviates acute brain injury in a rat model of traumatic brain injury: possible involvement of inflammatory signaling. Front Neurosci 12:1–9. https://doi.org/10.3389/fnins.2018.00657
Tayanloo-Beik A, Kiasalari Z, Roghani M (2022) Paeonol ameliorates cognitive deficits in streptozotocin murine model of sporadic Alzheimer’s disease via attenuation of oxidative stress, inflammation, and mitochondrial dysfunction. J Mol Neurosci 72(2):336–348. https://doi.org/10.1007/s12031-021-01936-1
Varela-Nallar L, Arredondo SB, Tapia-Rojas C, Hancke J, Inestrosa NC (2015) Andrographolide stimulates neurogenesis in the adult hippocampus. Neural Plast 2015:1–13. https://doi.org/10.1155/2015/935403
Vogel-Ciernia A, Wood MA (2014) Examining object location and object recognition memory in mice. Curr Protoc Neurosci 69(1):8.31.1-8.31.17. https://doi.org/10.1002/0471142301.ns0831s69
Walsh RN, Cummins RA (1976) The open-field test: a critical review. Psychol Bull 83(3):482–504. https://doi.org/10.1037/0033-2909.83.3.482
Wang D, Yin H, Lin Q, Fang S-P, Shen J-H, Wu Y-F, Su S-H, Hai J (2019) Andrographolide enhances hippocampal BDNF signaling and suppresses neuronal apoptosis, astroglial activation, neuroinflammation, and spatial memory deficits in a rat model of chronic cerebral hypoperfusion. Naunyn-Schmiedeberg’s Arch Pharmacol 392(10):1277–1284. https://doi.org/10.1007/s00210-019-01672-9
Wong SY, Tan MGK, Wong PTH, Herr DR, Lai MKP (2016) Andrographolide induces Nrf2 and heme oxygenase 1 in astrocytes by activating p38 MAPK and ERK. J Neuroinflammation. https://doi.org/10.1186/s12974-016-0723-3
Xu Y, Tang D, Wang J, Wei H, Gao J (2019) Neuroprotection of andrographolide against microglia-mediated inflammatory injury and oxidative damage in PC12 neurons. Neurochem Res 44(11):2619–2630. https://doi.org/10.1007/s11064-019-02883-5
Zafeer MF, Firdaus F, Anis E, Mobarak Hossain M (2019) Prolong treatment with Trans-ferulic acid mitigates bioenergetics loss and restores mitochondrial dynamics in streptozotocin-induced sporadic dementia of Alzheimer’s type. Neurotoxicology 73:246–257. https://doi.org/10.1016/j.neuro.2019.04.006
Zappa Villar MF, López Hanotte J, Falomir Lockhart E, Trípodi LS, Morel GR, Reggiani PC (2018) Intracerebroventricular streptozotocin induces impaired Barnes maze spatial memory and reduces astrocyte branching in the CA1 and CA3 hippocampal regions. J Neural Transm 125(12):1787–1803. https://doi.org/10.1007/s00702-018-1928-7
Zhang J, Zheng Y, Zhao Y, Zhang Y, Liu Y, Ma F, Wang X, Fu J (2021) Andrographolide ameliorates neuroinflammation in APP/PS1 transgenic mice. Int Immunopharmacol 96:107808. https://doi.org/10.1016/j.intimp.2021.107808
Zhu Y, Peng L, Hu J, Chen Y, Chen F (2019) Current anti-Alzheimer’s disease effect of natural products and their principal targets. J Integr Neurosci 18(3):327. https://doi.org/10.31083/j.jin.2019.03.1105
Acknowledgements
We thank Professor Marcelo M.S. Lima (Department of Physiology, Federal University of Parana) for allowing us to conduct part of the experiments in the facilities of the Laboratory of Neurophysiology and Professor Silvio M. Zanata (Department of Basic Pathology, Federal University of Parana) for the support.
Funding
This work was supported by grants from Coordination for the Improvement of Higher Education Personnel (CAPES) and Araucaria Foundation to Support Scientific and Technological Development of the State of Paraná (No. 88882.168580/2018–01), which had no further role in the study design, collection, analysis, and interpretation of the data, writing the report, and decision to submit the paper for publication. MABFV is a recipient of a National Council for Scientific and Technological Development (CNPq) fellowship (No. 309567/2019–0).
Author information
Authors and Affiliations
Contributions
Leonardo C. Souza contributed to the conceptualization, methodology, validation, formal analysis, investigation, data curation, writing—original draft, writing—review and editing, and visualization. Marcos K. Andrade and Evellyn M. Azevedo were involved in the formal analysis, investigation, and data curation.. Daniele C. Ramos contributed to the investigation and writing—review and editing. Ellen L. Bail contributed to the investigation. Maria A. B. F. Vital helped in the conceptualization, methodology, resources, writing—review and editing, visualization, supervision, project administration, and funding acquisition.
Corresponding author
Ethics declarations
Ethics Approval
The experiments were performed following the Brazilian Law for Animal Experimental Ethics and Care (11.794/October 8, 2008) and the guidelines of the UFPR Committee on the Care and Use of Laboratory Animals.
Conflict of Interest
The authors report no conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Souza, L.C., Andrade, M.K., Azevedo, E.M. et al. Andrographolide Attenuates Short-Term Spatial and Recognition Memory Impairment and Neuroinflammation Induced by a Streptozotocin Rat Model of Alzheimer’s Disease. Neurotox Res 40, 1440–1454 (2022). https://doi.org/10.1007/s12640-022-00569-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12640-022-00569-5